Targeted Disease(s):
COPD
Purpose of Study:
This is a prospective, randomized, parallel group, double-blind, sham-controlled, multicenter clinical trial following patients to 2 years. The objective is to assess the safety and effectiveness of Bronchial Rheoplasty for the treatment of the symptoms of chronic bronchitis in adult COPD patients with moderate to severe chronic bronchitis. A total of 270 patients will be randomized at up to 40 study centers in the United States, Canada, and Europe.
Study Dates:
April 7, 2021 - January 1, 2024
Study Location:
Nationwide
Lead Institution:
University of Pittsburgh Medical Center and Karl-Landsteiner-Institute for Lung Research and Pulmonary Oncology
Funding Source:
Private
ClinicalTrails.gov Identifier:
NCT04677465
Sponosor: Gala Therapeutics, Inc.
